Arcadia Biosciences, Inc. (NASDAQ:RKDA) is reporting second quarter earnings results on Thursday 13th August 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.59 per share.
For the full year, analysts predict revenues of $ 10.02 million, while looking forward to loss of $ 1.26 per share.
Previous Quarter Performance
Arcadia Biosciences, Inc. posted income for the first quarter of $ 0.29 per share, from the revenue of $ 0.31 million. The consensus estimates are loss of $ 0.54 per share from $ 0.80 million in revenue. The bottom line results beat street analysts by $ 0.83 or 153.70 percent, at the same time, top line results fell short of analysts by $ 0.49 million or 61.25 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Arcadia Biosciences, Inc.
Stock Performance
According to the previous trading day, closing price of RKDA was $ 3.87, representing a 68.26 % increase from the 52 week low of $ 2.30 and a 62.06 % decrease over the 52 week high of $ 10.20.
The company has a market capital of $ 41.36 million and is part of the Basic Materials sector and Agricultural Inputs industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”RKDA” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and Wheat Yield traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand.
